Danske Bank’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
Other funds holding ATHE
PFGI
Danske Bank's ATHE Position: Q3 2026 in Review
Danske Bank held its Alterity Therapeutics (ATHE) position steady in Q3 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1092.
Danske Bank first reported a position in ATHE in Q3 2024 and has held it in 9 quarters since. The position peaked at $5 in Q2 2026. 22 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.
- Danske Bank held 1 share of Alterity Therapeutics worth $4 as of Q3 2026.
- Danske Bank left its Alterity Therapeutics share count unchanged in Q3 2026.
- Alterity Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1092 holding.
- Danske Bank first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 9 quarters since.
- Danske Bank's Alterity Therapeutics position peaked at $5 in Q2 2026.
- 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.